Despite an aggressive media hit job on the 40 year-old Nobel Prize-winning drug, a recent study, coupled with the rising rates of RSV in children, has thrust ivermectin into the spotlight once again. Is the controversial drug the key to fighting RSV?
Published on 3 years, 1 month ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate